Skip to main content

Advertisement

SpringerLink
Log in

Takayasu’s arteritis

  • Published:
Current Rheumatology Reports Aims and scope Submit manuscript

Abstract

The frequency of Takayasu’s arteritis (TA) has been estimated to be 2.9 cases per 1 million people, with a female preponderance, although female-to-male ratio varies from different geographic areas. A high frequency of haplotype A24-B52-DR2 has been found in Japanese patients, without this association in other populations. TA has a striking predilection for the aortic arch and its branches. Evidence favors an autoimmune pathogenesis. Segmental inflammation (active and inactive lesions) may coexist. Due to its enhanced resolution, magnetic resonance imaging and magnetic resonance angiography eventually will replace catheterization angiography. Mortality reduction with glucocorticoid treatment has not been firmly established.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Adams R: Case of disease of the heart with pathological observations. Dublin Hosp Reports Commun Med Surg 1827, 74:443.

    Google Scholar 

  2. Davy I: Notice of a case, the arterial-innominate and the left subclavian and carotid arteries were closed without loss of life. Physiol Anat 1839, 26pp. Smith P. Elder.

  3. Takayasu M: Case with unusual changes of the central vessels in the retina. Acta Soc Ophthalmol Jpn 1908, 12:554.

    Google Scholar 

  4. Saito Y, Hirota K, Ito I, et al.: Clinical and pathological studies of five autopsied cases of aortitis syndrome, I: Findings of the aortic arch and its branches, peripheral arteries and pulmonary arteries. Jpn Heart J 1972, 13:20–33.

    PubMed  CAS  Google Scholar 

  5. Lupi-Herrera E, Sánchez-Torres G, Marcushamer J, et al.: Takayasu’s arteritis. Clinical study of 107 cases. Am Heart J 1977, 93:94–103.

    Article  PubMed  CAS  Google Scholar 

  6. Barker NW, Edwards IE: Primary arteritis of the aortic arch. Circulation 1955, 11:486–492.

    PubMed  CAS  Google Scholar 

  7. Ross RS, McKusick VA: Aortic arch syndrome (diminished or absent pulses in arteria arising from arch of aorta). Arch Int Med 1953, 46:313–324.

    Google Scholar 

  8. Burnstein J, Lindstrom B, Wasastjerna C: Aortic arch syndrome. A survey of five cases. Acta Medica Scand 1957, 157:365–378.

    Google Scholar 

  9. Shimizu K, Sano K: Pulseless disease. J Neuropathol Clin Neurol 1951, 1:37–47.

    Google Scholar 

  10. Learmonth BC: Report of 16 cases of sudden aortic occlusion. Edinburgh Med J 1952:59.

  11. Marquis Y, Richardson JB, Ritchie AC: Idiopathic medial artopathy and arteriopathy. Am J Med 1968, 44:939–954.

    Article  PubMed  CAS  Google Scholar 

  12. Ishikawa K: Natural history and classification of occlusive thromboaortopathy (Takayasu’s disease). Circulation 1978, 57:27–35.

    PubMed  CAS  Google Scholar 

  13. Sharma BK, Jain S, Radotra BD: An autopsy study of Takayasu arteritis in India. Int J Cardiol 1998, 66:S85–90. Autopsy findings of 10 patients with Takayasu arteritis are reported. Active arterial inflammatory lesions were present despite a clinically silent phase of the disease. Mortality in Indian patients with TA is due to severe uncontrolled hypertension and its effect on heart, kidney, and brain.

    Article  PubMed  Google Scholar 

  14. Ito I: Aortitis syndrome with reference to detection of antiaorta antibody from patients’ sera. Jpn Circ J 1966, 30:75.

    Google Scholar 

  15. Asherson RA, Asherson G, Schrire V: Immunological studies in arteritis of the aorta and great vessels. Br Med J 1968, iii:589.

    Google Scholar 

  16. Baltazares M, Mendoza F, Dabague J, Reyes PA: Antiaorta antibodies and Takayasu arteritis. Int J Cardiol 1998, 66:S183–187.

    Article  PubMed  Google Scholar 

  17. Inder SJ, Bobryshev YV, Cherian SM, et al.: Immunophenotypic analysis of the aortic wall in Takayasu’s arteritis: involvement of lymphocytes, dendritic cells and granulocytes in immunoinflammatory reactions. Cardiovasc Surg 2000, 8:141–148. This study shows that immune inflammation is present in Takayasu’s disease, and that the interactions between dendritic cells, smooth muscle cells, endothelial cells, and lymphocytes may be important to control this disease.

    Article  PubMed  CAS  Google Scholar 

  18. Blank M, Krause I, Goldkorn T, et al.: Monoclonal antiendothelial cell antibodies from a patient with Takayasu arteritis activate endothelial cells from large vessels. Arthritis Rheum 1999, 42:1421–1432. Monoclonal anti-endothelial cell antibodies may increase the nuclear translocation of the NF-κB transcription factor and directly stimulate EC through elevation of adhesion molecule expression associated and adhesion of monocytes, and may play a pathogenic role in the vasculopathy of Takayasu arteritis.

    Article  PubMed  CAS  Google Scholar 

  19. Numano F: Vasa vasoritis, vasculitis and atherosclerosis. Int J Cardiol 2000, 75:S1–8.

    Article  PubMed  Google Scholar 

  20. Numano F, Kishi Y, Tanaka A, et al.: Inflammation and atherosclerosis. Atherosclerotic lesions in Takayasu arteritis. Ann NY Acad Sci 2000, 902:65–76. The presence of atherosclerotic complications in young female patients with Takayasu arteritis, generally without traditional atherosclerosis risk factors, may show that inflammation is an important risk factor in atherogenesis.

    Article  PubMed  CAS  Google Scholar 

  21. Fraga A, Cobos F, Chávez M, et al.: Increased levels of homocysteine in Takayasu’s arteritis. Arthritis Rheum 2000, 43:S128.

    Google Scholar 

  22. Ishohjsa I, Numano F, Maezawa H, Sasazuk P: HLA-BW52 in Takayasu’s disease. Tissue Antigens 1979, 12:246–248.

    Google Scholar 

  23. Rodríguez-Reyna TS, Zúñiga-Ramos J, Salgado N, et al.: Intron 2 and exon 3 sequences may be involved in the susceptibility to develop Takayasu arteritis. Int J Cardiol 1998, 66:S135–138.

    Article  PubMed  Google Scholar 

  24. Vargas-Alarcón G, Zuniga J, Gamboa R, et al.: DNA sequencing of HLA-B alleles in Mexican patients with Takayasu arteritis. Int J Cardiol 2000, 75:S117–122. Sequence analysis defined that the subtypes present in Mexican population are B*3908, B*1510, B*1515, B*1522, B*1531, B*4005, and B*4008. These findings shows that most of the Mexican patients share two epitopes described in Asian populations, suggesting that these epitopes could be responsible for the susceptibility to develop the disease.

    Article  PubMed  Google Scholar 

  25. Seko Y: Takayasu arteritis: insights into immunopathology. Jpn Heart J 2000, 41:15–26. Association with a specific haplotype of MHC class I chain-related (MIC) or MICA gene with TA, suggests that the HLA-linked gene susceptible to the disease is mapped near the MICA gene.

    Article  PubMed  CAS  Google Scholar 

  26. Strachan RW: Natural history of Takayasu’s arteriopathy. Q J Med 1964, 33:57–69.

    PubMed  CAS  Google Scholar 

  27. Fraga A, Mintz G, Valle L, Flores-Izquierdo G: Takayasu’s arteritis: frequency of systemic manifestations and favorable response to maintenance therapy with adreno-corticosteroids. Arthritis Rheum 1972, 15:617–624.

    Article  PubMed  CAS  Google Scholar 

  28. Baba T, Itakura K, Tanaka R, et al.: Importance of fluorescein angiographic study in evaluating early retinal changes in Takayasu disease. Jpn J Ophthalmol 1999, 43:546–552.

    Article  PubMed  CAS  Google Scholar 

  29. Bouzas EA, Karadimas P, Alexandrou A, Panagopoulos I: Epiretinal membrane in association with Takayasu disease. Acta Ophthalmol Scand 1999, 77:483–484.

    Article  PubMed  CAS  Google Scholar 

  30. Lupi EH, Sanchez G, Harowitz S, Gutierrez E: Pulmonary artery involvement in Takayasu’s arteritis. Chest, 1975, 67:69–74.

    PubMed  CAS  Google Scholar 

  31. Kiyosawa M, Baba T: Ophthalmological findings in patients with Takayasu disease. Int J Cardiol 1998, 66:S141–147.

    Article  PubMed  Google Scholar 

  32. Spencer R, Tolentino FI, Doyle GJ: Takayasu’s arteritis: case report and review emphasizing ocular manifestations. Ann Ophthalmol 1980, 12:935–938.

    Google Scholar 

  33. Hall S, Barr W, Lie JT, et al.: Takayasu arteritis: a study of 32 North American patients. Medicine 1985, 64:89–99.

    Article  PubMed  CAS  Google Scholar 

  34. Nakabayashi K, Nitadori T, Kamiya Y, Nagasawa T: Atypical Takayasu arteritis: late onset and arthritic manifestations: Report of two cases. Int J Cardiol 1998, 66:S221–227.

    Article  PubMed  Google Scholar 

  35. Perniciaro CV, Winkelmann RK, Hunder GG: Cutaneous manifestations of Takayasu’s arteritis: a clinicopathologic correlation. J Am Acad Dermatol 1987, 17:998–1005.

    Article  PubMed  CAS  Google Scholar 

  36. Sharma BK, Jain S: A possible role of sex in determining distribution of lesions in Takayasu arteritis. Int J Cardiol 1998, 66:S81–4. The authors suggests that Indian male patients with TA have a higher frequency of hypertension and abdominal aorta involvement, whereas female patients have involvement of aortic arch and its branches.

    Article  PubMed  Google Scholar 

  37. Wiggelinkhuizen J, Cremin BJ: Takayasu’s arteritis and renovascular hypertension in childhood. Pediatrics 1978, 62:209–217.

    PubMed  CAS  Google Scholar 

  38. Roberts WC, MacGregor RR, De Blanc HJ: The prepulseless phase of pulseless disease or pulseless disease with pulses. Am J Med 1969, 46:313–324.

    Article  PubMed  CAS  Google Scholar 

  39. Cipriano PR, Silverman JF, Perlrhot MG, et al.: Coronary arterial narrowing, III: Takayasu’s aortitis. Am J Cardiol 1977, 39:744–750.

    Article  PubMed  CAS  Google Scholar 

  40. Janzen J, Vuong PN, Rothenberger-Janzen K: Takayasu’s arteritis and fibromuscular dysplasia as causes of acquired atypical coarctation of the aorta: retrospective analysis of seven cases. Heart Vessels 1999, 14:277–282.

    PubMed  CAS  Google Scholar 

  41. Ghosh S, Sinha DP, Ghosh S, et al.: Dilated cardiomyopathy in non-specific aortoarteritis. Indian Heart J 1999, 51:527–531. The authors found dilated cardiomyopathy in 5% (12 of 195) of cases of Takayasu’s arteritis and conclude that is not rare, although not much reported, and can influence the prognosis of aortoarteritis cases.

    PubMed  CAS  Google Scholar 

  42. Elsasser S, Soler M, Bolliger C, et al.: Takayasu disease with predominant pulmonary involvement. Respiration 2000, 67:213–215.

    Article  PubMed  CAS  Google Scholar 

  43. Haque U, Hellmann D, Traill T, et al.: Takayasu’s arteritis involving proximal pulmonary arteries and mimicking thromboembolic disease. J Rheumatol 1999, 26:450–453. This paper describes a patient with Takayasu’s arteritis that mimicked thromboembolic disease.

    PubMed  CAS  Google Scholar 

  44. Rizzi R, Bruno S, Stellacci C, Dammacco R: Takayasu’s arteritis: a cell-mediated large-vessel vasculitis. Int J Clin Lab Res 1999, 29:8–13. Adequate review with emphasis on clinical picture and prognosis.

    Article  PubMed  CAS  Google Scholar 

  45. Takeshita A, Tanaka S, Orita Y, et al.: Baroreflex sensitivity in patients with Takayasu’s aortitis. Circulation 1977, 55:803–806.

    PubMed  CAS  Google Scholar 

  46. Zlatkin S, Aamar S, Specter G, et al.: Takayasu’s arteritis identified by computerized tomography: revealing the submerged portion of the iceberg?. Isr Med Assoc J 1999, 1:245–249. The authors suggest that epigastric tenderness due to inflammatory reaction in the abdominal aortic wall should be considered as a diagnostic criterion of Takayasu’s aortitis. The use of CT and MRI technologies may reveal missed cases.

    PubMed  CAS  Google Scholar 

  47. Usui J, Takemura H, Yuhara T, et al.: Dieulafoy’s lesion of the esophagus as a probable complication of Takayasu’s arteritis. J Rheumatol 1999, 26:454–456.

    PubMed  CAS  Google Scholar 

  48. Todini AR, Heinzmann MM, Antignani PL, Paiella ML: Association between Takayasu’s arteritis and Crohn’s disease in two young women: Case reports. J Mal Vasc 1999, 24:373–376.

    PubMed  CAS  Google Scholar 

  49. Kawashima M, Koike R, Nishio J, et al.: A case of Takayasu’s arteritis with ulcerative colitis diagnosed by carotodynia and MRI findings. Nihon Rinsho Meneki Gakkai Kaishi 1999, 22:317–323.

    PubMed  CAS  Google Scholar 

  50. Munir I, Uflacker R, Milutinovic J: Takayasu’s arteritis associated with intrarenal vessel involvement. Am J Kidney Dis 2000, 35:950–953.

    PubMed  CAS  Google Scholar 

  51. Sharma BK, Jain S, Vasishta K: Outcome of pregnancy in Takayasu arteritis. Int J Cardiol 2000, 75:S159–162. The authors report 24 pregnancies: two resulting in abortion and five resulting in intrauterine death. Of 17 live babies born, intrauterine growth retardation was present in five and premature deliveries encountered in four.

    Article  PubMed  Google Scholar 

  52. Shingadia D, Das L, Klein-Gitelman M, Chadwick E: Takayasu’s arteritis in a human immunodeficiency virus-infected adolescent. Clin Infect Dis 1999, 29:458–459.

    PubMed  CAS  Google Scholar 

  53. Hoffman GS, Ahmed AE: Surrogate markers of disease activity in patients with Takayasu arteritis. A preliminary report from The International Network for the Study of the Systemic Vasculitides (INSSYS). Int J Cardiol 1998, 66:S191–194. Multiple serologic tests were performed including ESR, C-reactive protein, tissue factor, von Willebrand factor, thrombomodulin, tissue plasminogen activator, ICAM-1, VCAM-1, E-selectin, and PECAM-1. No test could reliably distinguish between healthy volunteers and patients with active Takayasu arteritis.

    Article  PubMed  Google Scholar 

  54. Noguchi S, Numano F, Gravanis MB, Wilcox JN: Increased levels of soluble forms of adhesion molecules in Takayasu arteritis. Int J Cardiol 1998, 6:S23–33. The data suggest that the measurement of soluble vascular cell adhesion molecule-1 may be clinically important in Takayasu arteritis.

    Article  Google Scholar 

  55. Nava A, Senecal JL, Banales JL, et al.: Absence of antiphospholipid/ co-factor antibodies in Takayasu arteritis. Int J Cardiol 2000, 75:S99-S104.

    Article  PubMed  Google Scholar 

  56. Berkmen YM, Lande A: Chest roentgenography as a window to the diagnosis of Takayasu’s arteritis. Am J Roentgenol Radium Ther Nucl Med 1975, 125:842–846.

    PubMed  CAS  Google Scholar 

  57. Hata A, Noda M, Moriwaki R, Numano F: Angiographic findings of Takayasu arteritis: new classification. Int J Cardiol 1996, 54:S155–163.

    Article  PubMed  Google Scholar 

  58. Suwanwela NC, Suwanwela N: Takayasu arteritis: Ultrasonographic evaluation of the cervico-cerebral arteries. Int J Cardiol 1998, 66:S163–173.

    Article  PubMed  Google Scholar 

  59. Raninen RO, Kupari MM, Pamilo MS, et al.: Ultrasonography in the quantification of arterial involvement in Takayasu’s arteritis. Scand J Rheumatol 2000, 29:56–61.

    Article  PubMed  CAS  Google Scholar 

  60. Paul JF, Hernigou A, Lefebvre C, et al.: Electron beam CT features of the pulmonary artery in Takayasu’s arteritis. AJR Am J Roentgenol 1999, 173:89–93.

    PubMed  CAS  Google Scholar 

  61. Pinheiro LW, LeBlang SD, Romano J, Forteza A: The acute diagnosis of Takayasu’s arteritis based on helical CT angiography of the chest and neck in the emergency room. AJNR Am J Neuroradiol 1999, 20:1983–1985.

    PubMed  CAS  Google Scholar 

  62. Mesurolle B, Qanadli SD, Merad M, et al.: Dual-slice helical CT of the thoracic aorta. J Comput Assist Tomogr 2000, 24:548–556.

    Article  PubMed  CAS  Google Scholar 

  63. Yamada I, Nakagawa T, Himeno Y, et al.: Takayasu arteritis: diagnosis with breath-hold contrast-enhanced three-dimensional MR angiography. J Magn Reson Imaging 2000, 11:481–487. The sensitivity and specificity of magnetic resonance angiography for the diagnosis of Takayasu arteritis were both 100%. Breath-hold contrast-enhanced three-dimensional MR angiography clearly shows diverse vascular lesions in systemic and pulmonary arteries, allowing a definitive diagnosis of Takayasu arteritis.

    Article  PubMed  CAS  Google Scholar 

  64. Hoffmann M, Corr P, Robbs J: Cerebrovascular findings in Takayasu disease. J Neuroimaging 2000, 10:84–90. Cerebral effects of Takayasu’s arteritis are best monitored by a combination of clinical and functional imaging such as TCD and SPECT scanning.

    PubMed  CAS  Google Scholar 

  65. Choe YH, Han BK, Koh EM, et al.: Takayasu’s arteritis: assessment of disease activity with contrast-enhanced MR imaging. AJR Am J Roentgenol 2000, 175:505–511. High-resolution contrast-enhanced T1-weighted spinecho MR imaging in patients with Takayasu’s arteritis seems to show more enhancement of thickened aortic wall compared with myocardium, thus suggesting lesions of active arteritis, which may be useful in the diagnosis and treatment of Takayasu’s arteritis.

    PubMed  CAS  Google Scholar 

  66. Watanabe Y, Dohke M, Okumura A, et al.: dynamic subtraction contrast-enhanced MR angiography: technique, clinical applications, and pitfalls. Radiographics 2000, 20:135–152.

    PubMed  CAS  Google Scholar 

  67. Flamm SD, White RD, Hoffman GS: The clinical application of ‘edema-weighted’ magnetic resonance imaging in the assessment of Takayasu’s arteritis. Int J Cardiol 1998, 66:S151–159.

    Article  PubMed  Google Scholar 

  68. Choe YH, Kim DK, Koh EM, et al.: Takayasu arteritis: Diagnosis with MR imaging and MR angiography in acute and chronic active stages. J Magn Reson Imaging 1999, 10:751–757.

    Article  PubMed  CAS  Google Scholar 

  69. Cantú C, Pineda C, Barinagarrementería F, et al.: Noninvasive cerebrovascular assessment of Takayasu arteritis. Stroke 2000, 31:2197–2202.

    PubMed  Google Scholar 

  70. Arend WP, Michel BA, Bloch DA, et al.: The American College of Rheumatology 1990 criteria for the classification of Takayasu’s arteritis. Arthritis Rheum 1990, 33:1129–1134.

    Article  PubMed  CAS  Google Scholar 

  71. Gibbons IB, King RL: Obliterative brachiocephalic arteritis (Pulseless disease). Circulation 1957, 15:845–849.

    PubMed  CAS  Google Scholar 

  72. Kitamura H, Kobayashi Y, Kimura A, Numano F: Association of clinical manifestations with HLA-B alleles in Takayasu arteritis. Int J Cardiol 1998, 66:S121–126.

    Article  PubMed  Google Scholar 

  73. Ishikawa K: Effects of prednisolone therapy on arterial angiographic features in Takayasu’s disease. Am J Cardiol 1991, 68:410–413.

    Article  PubMed  CAS  Google Scholar 

  74. Shelhamer JH, Volkman DJ, Parrillo JE, et al.: Takayasu’s arteritis and its therapy. Ann Intern Med 1985, 103:121–126.

    PubMed  CAS  Google Scholar 

  75. Hoffman GS, Leavitt RY, Kerr GS, et al.: Treatment of glucocorticoid-resistant or relapsing Takayasu arteritis with methotrexate. Arthritis Rheum 1994, 37:578–582.

    Article  PubMed  CAS  Google Scholar 

  76. Daina E, Schieppati A, Remuzzi G: Mycophenolate mofetil for the treatment of Takayasu arteritis: report of three cases. Ann Intern Med 1999, 130:422–426.

    PubMed  CAS  Google Scholar 

  77. Moncada GA, Hashimoto Y, Kobayashi Y, et al.: Usefulness of beta blocker therapy in patients with Takayasu arteritis and moderate or severe aortic regurgitation. Jpn Heart J 2000, 41:325–337. Beta-blocker therapy can slow and even reverse the progression of left ventricular hypertrophy in patients with Takayasu arteritis complicated by moderate or severe aortic regurgitation. These agents can be used safely alone or in addition to standard antihypertensive therapy to reduce excessive afterload.

    Article  PubMed  CAS  Google Scholar 

  78. Marsen TA, Sukau G, Pollok M, Baldamus CA: Enalapril and losartan augment endogenous nitric oxide release in Takayasu’s arteritis—a case report. Angiology 2000, 51:69–75. Renovascular hypertension in Takayasu’s arteritis is associated with an imbalance of endothelin-1 and vasodilator peptide NO. Successful treatment of hypertension by enalapril or losartan results in improved endogenous NO synthesis, which counterbalances excessive vasoconstrictor actions and may retard the progression of renal failure.

    Article  PubMed  CAS  Google Scholar 

  79. Iwai T, Inoue Y, Matsukura I, et al.: Surgical technique for management of Takayasu’s arteritis. Int J Cardiol 2000, 75:S135–140.

    Article  PubMed  Google Scholar 

  80. Sasaki S, Kubota S, Kunihara T, et al.: Surgical experience of the thoracic aortic aneurysm due to Takayasu’s arteritis. Int J Cardiol 2000, 75:S129–134.

    Article  PubMed  Google Scholar 

  81. Srivastava AK, Pandey S, Kapoor A: Radical aortic replacement employing simultaneous modified Bentall and elephant trunk procedure in Takayasu’s arteritis. J Cardiovasc Surg 2000, 41:117–120.

    CAS  Google Scholar 

  82. Giordano JM: Surgical treatment of Takayasu’s arteritis. Int J Cardiol 2000, 75:S123–128.

    Article  PubMed  Google Scholar 

  83. Sharma BK, Jain S, Bali HK, et al.: A follow-up study of balloon angioplasty and de-novo stenting in Takayasu arteritis. Int J Cardiol 2000, 75:S147–152.

    Article  PubMed  Google Scholar 

  84. Stoodley MA, Thompson RC, Mitchell RS, et al.: Neurosurgical and neuroendovascular management of Takayasu’s arteritis. Neurosurgery 2000, 46:841–851. Improvement of ischemic neurologic symptoms can be achieved with surgical revascularization.

    Article  PubMed  CAS  Google Scholar 

  85. Shindo S, Suzuki O, Kamiya K, Tada Y: Primary aortoduodenal fistula treated successfully with surgery in a patient with Takayasu’s arteritis. Int Angiol 1999, 18:244–246.

    PubMed  CAS  Google Scholar 

  86. Beale PG, Meyers KE, Thomson PV: Management of renal hypertension in children with Takayasu’s arteritis using renal autografting of allograft transplantation in selected circumstances and total lymphoid irradiation. J Pediatr Surg 1992, 27:836–839.

    Article  PubMed  CAS  Google Scholar 

  87. Sharma BK, Jain S, Radotra BD: An autopsy study of Takayasu arteritis in India. Int J Cardiol 1998, 66:S85–90. Autopsy findings of 10 patients with Takayasu arteritis are reported. Active arterial inflammatory lesions were present despite a clinically silent phase of the disease. Mortality in Indian patients with TA is due to severe uncontrolled hypertension and its effect on the heart, kidney, and brain.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Rheumatology Department, Centro Medico Nacional “Siglo XXI,” IMSS, México City, Mexico

    Antonio Fraga MD & Francisco Medina MD

Authors
  1. Antonio Fraga MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Francisco Medina MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fraga, A., Medina, F. Takayasu’s arteritis. Curr Rheumatol Rep 4, 30–38 (2002). https://doi.org/10.1007/s11926-002-0021-1

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11926-002-0021-1

Keywords

Search

Navigation